Abstract
EDITOR,—We challenge Fehmi Akcicek and colleagues' argument against the use of albumin in the nephrotic syndrome on two counts.1 The first concerns the selection of patients. The urinary protein loss, plasma creatinine concentration, and prior drug treatment are not given in their report, but we assume that the patients had not received either corticosteroids or diuretics. The mean excretion of 2.96 litres of water and 275 mmol of sodium after intravenous frusemide, implying weight loss of about …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
